AGFA HealthCare
MORTSEL, BELGIUM / ACCESSWIRE / May 14, 2024 / AGFA HealthCare is pleased to announce that St. Vincent's Private Hospital in Dublin, Ireland, has chosen to implement AGFA HealthCare's Enterprise Imaging. This five-year agreement includes Enterprise Imaging for both Radiology and Breast Imaging, structured and precision reporting modules, Best in KLAS XERO® Universal Viewer, AGFA's Scheduling solution, Business Intelligence, Patients and Clinician portal, and a Managed Services contract.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.Near-real-time image access
St. Vincent's Private Hospital is the largest acute private hospital in Dublin and part of the only integrated multi-hospital campus in Ireland. The Enterprise Imaging Platform will deliver the advanced capabilities and robust availability that the hospital needs.
"St. Vincent's Private Hospital is a unique healthcare environment. As we are on the same grounds as St. Vincent's University Hospital, we can share resources, expertise and medical facilities with this leading academic teaching establishment. This enables us to deal with a high volume of patients, often who have complex medical requirements. Imaging is core to this care. AGFA HealthCare's Enterprise Imaging will give us the reliable, robust platform that we need, whilst delivering very fast access to studies. Furthermore, AGFA HealthCare is able to support this system with managed services and monitoring that will maximise our uptime, while minimising the burden on our own resources," says Tim Aseervatham, Healthcare/Diagnostic Informatics Manager for St. Vincent's Private Hospital.
"We are proud of the trust that St. Vincent's Private Hospital - a key healthcare player in Ireland - is placing in AGFA HealthCare. This further demonstrates the success of our long-standing commitment to delivering solutions that improve the delivery of healthcare to patients in both the private and public healthcare sector in Ireland and beyond. Enterprise Imaging enables the creation of a secure, modular and scalable ecosystem, which helps the hospital to reduce complexity, improve clinical collaboration, and enhance workflow efficiency. By empowering all users to access imaging studies in near-real-time, it will allow them to focus on tasks that add value to both their patients' care and experience," says Colin Foley, Regional Business Manager for AGFA HealthCare Ireland.
Seamless care and collaboration
The Radiology Department at St. Vincent's Private Hospital is one of the largest radiology services in the country, offering a full range of diagnostic and interventional services. It performs over 65,000 studies every year, including X-ray, CT, mammography, MRI, ultrasound, fluoroscopy and DEXA. The department is made up of 18 consultant radiologists working in conjunction with highly qualified radiographers and nurses and supported by experienced administrators.
Enterprise Imaging will integrate with the hospital's existing pillar and patient referral systems and will replace all paper-based workflows. The five-year agreement includes:
- Enterprise Imaging for Radiology and Breast Imaging: a one-of-a-kind, seamless and secure platform designed to build a connected, collaborative, and scalable community of care. Enterprise Imaging delivers "life in flow" to meet radiologists' daily challenges through a highly focused, efficient and customisable experience.
- Best in KLAS XERO® Universal Viewer: provides patient-centric image access across the enterprise, with pixel streaming in near-real time on almost any device with no downloads or data moves, and enhanced viewing with clinical depth, collaboration and sharing, all on a single web viewer.
- Business Intelligence: enables easy-to-access reports and tools for gathering, organising, analysing and managing clinical, quality, financial and administrative data.
- Scheduling: facilitates managing appointments and orders for even the most complex imaging procedures in one easy and quick web-based application.
- Structured and precision reporting, including ACR BI-RADS® ATLAS and ACR PI-RADS® ATLAS: fully integrated in the Enterprise Imaging Platform, it combines customisation with automation to support clear communication and enhanced decision-making.
- Workflow orchestration: intelligently and automatically assigns tasks to radiologists, based on the chosen criteria.
- Collaboration tools: support multidisciplinary teams with the multimedia patient images they need, wherever they are, including at the point of care.
- Actionable findings notification: closes the loop between radiologists and clinicians through rapid and effective communication of incidental and critical imaging findings.
- Native 3D tools and advanced visualisation, plus seamlessly embedded third-party clinical application.
- Portal for patients and physicians: makes it easy for patients and physicians outside of the hospital to access medical images and results.
- Managed services and monitoring: support optimal maintenance and uptime of this flexible and high-performance solution.
We are delighted to welcome St Vincent's Hospital to #TeamAGFA and are honoured to add such a prestigious hospital to our customer base.
About AGFA HealthCare
At AGFA HealthCare, we are transforming the delivery of care - supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates - channelling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group. For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.
AGFA and the Agfa rhombus are registered trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. XERO® is a registered trademark of AGFA HealthCare N.V., Belgium. BI-RADS and PI-RADS are registered trademarks of the American College of Radiology. All rights reserved. All information contained herein is intended for guidance purposes only, and the characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible but shall not be responsible for any typographical error.
Contact Information
Buse Kayar
buse.kayar@issuerdirect.com
SOURCE: AGFA HealthCare
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom